Accelerating the Development of COVID-19 Vaccines with Clinical Remote Monitoring Solutions
In the dynamic world of clinical trials, innovative solutions are essential to overcome traditional challenges. Our latest case study, “Accelerating the development of COVID-19 vaccines with clinical remote monitoring solutions,” highlights how our clinical remote monitoring solutions are revolutionizing trial design and execution.
Key Highlights:
- Clinical Remote Monitoring: Our platform enabled over 6,000 participants to be monitored using wearable devices that collected vital sign data, ensuring near real-time monitoring and early intervention for complications.
- Global Trial Delivery: The phase 3 study involved 37,000+ participants across multiple regions, aiming to determine the safety, efficacy, and immunogenicity of a new drug and antibody.
- Advanced Technology: Wearable devices collected health data such as heart rate, respiration rate, and oxygen saturation. Providing near real-time monitoring of study participants at-home.
- Successful Outcomes: The study demonstrated the scalability and impact of remote monitoring, significantly improving participant safety and data accuracy.
Why This Matters
Our remote monitoring solutions provide a robust framework for continuous and intermittent vital sign data collection, and ePROs, helping to enhance participant safety and trial efficiency. This innovative approach not only achieves trial objectives but also sets a new standard for leveraging wearable technology in clinical research.
Learn More
To dive deeper into this groundbreaking study and discover how our remote monitoring solutions can revolutionize clinical trials, download our full case study now.
